Psych Flashcards
Anxiety diagnosis
AND I C REST Anxious, worried No control Duration >6mo of 3 or more of: - Irritability - Concentration impairment - Restlessness - Energy decreased - Sleep impairment - Tension in muscles
GAD-7 scores
5 = mild 10 = moderate 15 = severe
Best evidence-based treatment for anxiety
Cognitive behavioural therapy
Main brain structure involved in anxiety
Amygdala
Panic disorder diagnosis
STUDENTS FEAR the 3Cs Sweating Trembling Unsteadiness/dizziness Derealization/depersonalization Excessive heart rate Nausea Tingling SOB Fear of dying Chills, chest pain, choking
Treatment duration for panic disorder
Up to 1 year after symptoms resolve
Pharmacological choices for panic disorder
SSRIs
SNRIs
Benzos for short-term use
Often require higher doses for longer period of time than depression
Prognosis of panic disorder
6-10yrs post-treatment:
30% well
40-50% improved
20-30% no change or worse
Agoraphobia diagnosis
Marked fear or anxiety about 2 or more of: - using public transport - being in open spaces - being in enclosed places - standing in line or being in a crowd - being outside of home alone avoids these situations situations provoke fear or anxiety lasting >/=6mo Impairs functioning
First line pharmacological treatment for anxiety
SSRI and SNRIs
Second line pharmacological treatment for anxiety
Buspirone (TID dosing)
Bupropion
First line treatment for phobic disorders
CBT
Genetics and specific phobias
Tends to run in families
Blood-injection injury type phobias has high familial tendencies
Paroxetine
SSRI
- Paroxetine (Paxil) 20mg daily (take in morning), increase by 10mg/d at 1 week intervals
- Typically 20-50mg/d, but no greater benefit seen with doses >20mg
Sertraline
SSRI
* Sertraline (Zoloft) 25mg daily, increase by 25-50mg at intervals of >/= 1-2 wks
* Typically 50-150mg/d, max dose of 200mg/d
Safest in pregnancy and breastfeeding
Citalopram
SSRI
- Citalopram (Celexa) 10mg daily, increase by 10mg at >/= 1 week intervals
- Typically 40mg/d for adults = 60yrs and 20mg/d for adults >60yrs
Escitalopram
SSRI
- Escitalopram (Cipralex) 10mg daily, increase >/=1 wk intervals
- Max 20mg daily
Venlafaxine
SNRI
* Venlafaxine (Effexor) 37.5mg daily, increase by = 75mg/d increments at >/=4d intervals * Typically increase to 75mg after 4-7d * Typically 75-225mg daily, max 225mg/d
Duloxetine
SNRI
- Duloxetine (Cymbalta) 60mg daily or 30mg daily, increase by 30mg increments at >/= 1wk intervals
- Typically 60mg daily, max 120mg/d
Panic disorder associated with ___ in 50% of cases
Agoraphobia
Social anxiety disorder/social phobia is most commonly associated with
Substance abuse
1/2-3/4 of patients with SAD have co-occuring mental, drug or alcohol problems
Having social anxiety disorder increases your likelihood of depression by
~2-4x
Multiple personality syndrome and depersonalization has been strongly associated with
Hx of childhood sexual abuse
Nihilistic delusions
Belief that things do not exist; a sense that everything is unreal
Suicide risk factors
SAD PERSONS Sex (male) Age >60 Depression Previous attempts Ethanol abuse Rational thinking loss Suicide in family Organized plan No spouse/support Serious illness
Most common psychiatric disorders a/w completed suicide
Mood (bipolar > depression)
Alcohol abuse
Schizoprehnia dx
2 or more of the following, for at least 1 month, with at least one being one of the first three:
-Delusions
-Hallucinations
-Disorganized speech
-Grossly disorganized or catatonic behaviour
-Negative symptoms
Continuous signs of disturbance persist for at least 6 months
Decreased level of fxn
Echopraxia
Imitates movements and gestures of others
Schizophrenia linked to…
Substance related disorders
Anxiety disorders
Reduced life expectancy secondary to medical comrbidities
Antipsychotics
Risperidone
Aripiprazole
Haloperidole
Paliperidone
Last resort antipsychotic
Clozapine
Schizophrenia tx duration
At least 1-2yrs after first episode
At least 5yrs after multiple episodes
Schizophreniform d/o
Same criteria is schizophrenia but for at least 1 month and <6months
Return to baseline
60-80% progress to schizophrenia
Sex differences for schizophrenia
Male = female
Female dx later in life with bimodal distribution
Men = 10-25y.o,
Women = 25-35y.o.
Schizophreniform d/o
Same criteria is schizophrenia but for at least 1 month and <6months
Return to baseline
60-80% progress to schizophrenia
Schizophreniform epidemiology
Common in young adults/teens
Men»_space; women (5x)
Less common than schizo («1%)
Tx for schizophreniform d/o
Brief course of antipsychotic drugs (3-6mo)
Brief psychotic disorder
One or more of the following, with at least one being one of the first three: - Delusions - Hallucinations - Disorganized speech - Grossly disorganized behaviour More than 1d, less than 1 mo Eventual return to premorbid level of functioning ~50% go onto develop chronic psych
Schizoaffective d/o
Major mood eps CONCURRENT with Criterion A of schizo
Delusions/hallucinations for 2 or more weeks WITHOUT major mood eps during duration of illness
Major mood eps symptoms present for majority of total duration of active portions of illness
Schizoaffective epidemiology
Bipolar = equal in men and women, more common in young Depression = 2x more common in females. more common in older
Schizoaffective tx
Tx appropriate symptoms
BPD –> mood stabilizers
Depression –> SSRIs
Psychotics –> antipsychotics
Delusional d/o
> /= 1 delusion for 1 month or longer
Do not meet criterion A of schizo
Fxn not markedly impaired
Mania or major depressive epis brief relative to duration of delusions
Most freq subtype of delusional d/o
Persecutory
Depression
5 or more of the following symptoms for at least 2 weeks, with at least 1 being depression or decreased interest: Suicidal thoughts Interest decrease Guilt Energy low Concentration difficulty Appetite change Psychomotor changes Sleep issues
Mania
1 week period of elevated mood AND increased energy/goal-directed energy plus 3 of the following: DIGFAST - Distractibility - Indiscretion - Grandiosity - Flight of ideas - Activity increased - Sleep decreased - Talkativeness
Hypomanic episode
Mania but duration is >/= 4d and severity is not enough to cause marked impairment in social or occupational functioning
Mixed features mood disorder
While meeting full criteria for major drepressive episode, pt has on most days >/=3 criteria for manic episode
OR while meeting full criteria for manic/hypomanic episode, ptient has on most days >/= 3 criteria for depressive episode
Major depressive disorder
Presence of a MDE
Not better accounted for by schizoaffective d/o, not superimposed on schizophrenia, schizphreniform, delusional or psychotic d/o
No hx of manic episode or hypomanic
Fastest and most effective tx for MDD
ECT
1st line pharmacotherapy for MDD
SSRI: Sertraline, Escitalopram
SNRI: Venlafaxine
NaSSA: Mirtazapine
Typical response to antidepressants
Physical symptoms improve at 2wk
Mood/cognition by 4wk
If no improvement after 4wk at highest tolerated therapeutic dosage –> alter regimen
Persistent depressive disorder
Depressed mood for most of the day, for more days than not for >/= 2 yr Presence of >/=2 of: Sleep changes Eating changes Energy low Self-esteem low Poor concentration Feelings of hoeplessness Never without these symptoms during the 2 yr period for >2mo
Primary treatment for persistent depressive disorder
Psychotherapy
Postpartum blues
Normal
No psychotropic meds needed
Transient (2-4d postpartum, up to 10d)
Mild depression, mood instability, anxiety, decreased concentration
Usually mild or absent: feeling of inadequacy, anhedonia, thoughts of harming baby, suicidal thoughts
Major depressive disorder with peripartum onset
Postpartum Depression
MDD with onset during pregnancy or within 4wk following delivery
Typically lasts 2-6mo
Residual symptoms can last up to 1yr
Tx of MDD with peripartum onset
Psychotherapy
SSRI (safe short-term while breastfeeding)
If symptoms severe, consider ECT
Bipolar I Disorder
At least one manic episode
Commonly accompanied by at least 1 MDE but not required for dx
Usually MDE first, manic episode 6-10yrs after
Average age of first manic episode = 32yo
Bipolar II Disorder
At least 1 MDE, 1 hypomanic episode and no manic episodes
Bipolar treatment: Mania
Lithium
Anticonvulsants (divalproex, carbamazepine)
Antipsychotics
ECT if resistant
*MONOTHERAPY WITH ANTIDEPRESSANTS SHOULD BE AVOIDED
Agent with proven efficacy in preventing suicide attempts and completions
Lithium
Bipolar treatment: Depression
Lithium Lurasidone (atypical antipsychotic) Quetiapine (atypical antipsychotic) Lamotrigine (anticonvulsant) Antidepressants (only WITH mood stabilizer) ECT
Cyclothymia
- At least 2yrs (1 yr in children/adolescents), numerous periods with hypomanic symptoms that do not meet criteria for hypomanic episode and numerous periods with depressive symptoms that do not meet criteria for major depressive episode
- Hasn’t been without symptoms for more than 2mo at a time
Panic Disoder
Recurrent unexpected attacks - abrupt surge of fear or intense discomfort reaching peak within MINUTES during which time 4 or more of the following occur: STUDENTS FEAT THE 3 Cs - Palpitations, pounding heart, high HR - Sweating - Trembling/shaking - Blurred vision - Light-headedness - Chills or heat sensations - Paresthesias - Derealization - Fear or losing control - Fear of dying - Sensation of SOB or smothering - Feelings of choking - CP or discomfort - Nausea At least one attack followed by 1 mo or more of one or both of: - persistent corn or worry about more panic attacks or their consequences -Significant maladaptive change in behaviour related to attacks
Tx for Panic d/o
CBT
SSRI
SNRI
Tx for up to 1yr after symptoms resolve to avoid relapse
Anxiety vs depression tx
Anxiety often requires tx for longer and at higher doses than depression
Agoraphobia
At least 2 of more of the following: - fear of open spaces - fear of line ups - fear of enclosed spaces - fear of public transport - fear of being outside of house alone Fear for 6mo or more
Phobic disorder
Marked and persistent (>6mo) fear that is excessive or unreasonable, cued by presence or anticipation of a specific object or situation
Social anxiety disorder
Marked and persistent (>6mo) fear of social or performance situations in which one is exposed to unfamiliar ppl or to possible scrutiny by others; fearing he/she will act in a way that may be humiliating or embarassing
Obsessive Compulsive disorder
Presence of obsessions, compulsions or both
Obsessions: Recurrent and persistent thoughts, urges, or images that are intrusive and unwanted, cause anxiety, individual attempts to ignore or suppress thoughts
Compulsions: repetitive behaviours or mental acts that individual feels driven to perform in response to obsession. Behaviours meant to prevent/reduce anxiety or prevent some dreaded event but they are not connected realistically
Risk factors for OCD
Neuro dysfunction Family hx Adverse childhood experiences Exposure to traumatic events Group a strep infection (PANDAS)
Tx for OCD
CBT (exposure with response prevention)
SSRIs/SNRIs (12-16wk trials, higher dosages than used for depression), adjunctive antipsychotics (risperidone)
Clomipramine (TCA)
Body dysmorphic disorder
Preoccupation with >/=1 perceived flaws in physical appearance not observed by others
Repetitive behaviours or mental acts related to appearance
PTSD
TRAUMA Traumatic event Re-experience the event Avoidance of stimuli associated with trauma Unable to function More than a month Arousal increased \+ negative alterations in cognition and mood
PTSD tx
Psychotherapy, CBT
SSRI
Prazosin (treating disturbing dreams and nightmares)
Adjunctive atypical antipsychotics (risperidone, quetiapine)
Eye movement desensitization and reprocessing (EMDR)
Adjustment disorder
Emotional or behavioural symptoms in response to an identifiable stressor(s) occurring within 3mo of onset of stressor(s)
Once stressor has terminated, symptoms do not persist for more than an additional 6mo
Adjustment disorder tx
Brief psychotherapy
Benzodiazepine for significant anxiety
Antipsychotic options for delirium tx
Low doses of haloperidol IV or IM
Risperidone, olaznapine
Dementia
Significant cog decline from previous performance in 1 or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor or social cognition) based on both individual/clinician/family and standardized testing
Most common form of dementia
Alzheimer’s
Classic feature of alzheimer’s
Predominantly memory and learning issues
Classic feature of Lewy body dementia
Recurrent soft visual hallucinations
Autonomic impairment (falls, hypotension)
EPS/Parkinsonian features (cogwheeling, bradykinesia, resting tremor)
Does not respond well to pharmacotherapy
Fluctuating degree of cognitive impairment
Classic feature of vascular disease
Focal neurological signs
Abrupt onset
Pharmacological therapy for dementia
Mild-severe dz: Indirect holinesterase inhibitors
Mod-severe dz: Non-competitive NMDA receptor antagonist
Low-dose antipsychotics
Cholinesterase inhibitors x3
Donepezil (Aricept)
Rivastigmine
Galantamine
NMDA receptor antagonist x 1
Memantine
Low dose antipsychotics that can be used for dementia behavioural symptoms
Risperidone
Quetiapine
MOCA score
26/30 or above is considered normal
Indications for ECT as 1st line tx
Acute suicidal ideation MDE with psychotic features Tx resistant depression Catatonia Prior favourable response Repeated med failures Rapidly deteriorating physical status During pregnancy Patient choice
3 most common causes of dementia in pts over 65
Alzheimer’s
Vascular
Mixed vascular and Alzheimer’s
Hallmark neuropathology in alzheimer’s
Amyloid deposits
Neurofibrillary tangles
Neuronal loss esp in cortex and hippocampus
Synaptic loss
Hallmark neuropathology in frontotemporal dementia
Atrophy in frontotemporal regions
Neuronal pick bodies (masses of cytoskeletal elements) hence AKA Pick’s disease
Criteria for substance use disorder
PEC WITH MCAT
- use despite Physical or Psychological problems
- failures in important External roles (work/school/home)
- Craving or strong desire to use substance
- Withdrawal
- continued use despite Interpersonal problems
- Tolerance needing to use more substance to get same effect
- use in Hazardous situations
- More substance used or for longer period than intended
- unsuccessful attempts to Cut down
- Activities given up due to substance
- excessive Time spent on using or finding substance
CAGE questionnaire
ever felt the need to Cut down on drinking
ever felt Annoyed at criticism of your drinking
ever felt Guilty about your drinking
Eye opener
Men: score >/= 2 is +ve
Women: score >/= 1 if +ve
Drinking guidelines
Men: 3 or less/d (= 15/wk)
Women: 2 or less/d (= 10/wk)
Elderly: 1 or less/d
CIWA basic protocol
Diazepam PRN until CIWA <10
Thiamine x 3d
If >65 or hx of liver dz –> lorazepam instead
Haloperidol if hallucinations present or atypical antipsychotics (olanzapine, risperidone)